Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of children after acute pyelonephritis or recurrent urinary tract infection to prevent renal scarring
2009-012696-97Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in urinary tract infection (UTI), acute pyelonephritis and vesicoureteral reflux (VUR) comparing Amoxicillin plus beta-lactamase inhibitor arm with Cefaclor arm (2 arms). Primary endpoints: Number of acute pyelonephritis and urinary tract infection episodes, Number of new renal scars and 4 more. Started Jul 2009; status: active.
02
Drugs
amoxicillin + clavulanatecefaclor
03
Conditions
urinary tract infection (UTI)acute pyelonephritisvesicoureteral reflux (VUR)
Beyond the preview
Go deeper on 2009-012696-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012696-97.